+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Implant Market Overview, 2024-2029

  • PDF Icon


  • 98 Pages
  • March 2024
  • Region: Global
  • Bonafide Research
  • ID: 5969238
10% Free customization
1h Free Analyst Time
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical implants play a transformative role in modern medicine, offering solutions for a wide range of health conditions. From restoring lost limbs and repairing fractures to regulating heart rhythms and replacing failing organs, these advanced medical devices have revolutionized healthcare, improving patient outcomes and enhancing quality of life. The global medical implant market is a complex and dynamic ecosystem, encompassing a diverse array of technologies catering to numerous medical specialties. Understanding the specific applications of medical implants across various regions provides valuable insights into the unique healthcare priorities and challenges that shape this market.

Beyond the well-established applications in orthopedics, cardiology, and ophthalmology, the global medical implant landscape is witnessing a surge in innovative solutions for niche medical needs. One such area of significant growth is the field of neuromodulation. Neuromodulatory implants are devices that interact with the nervous system to treat various neurological and psychiatric disorders. Deep brain stimulation (DBS) implants, for instance, offer a glimmer of hope for patients with Parkinson's disease, essential tremor, and even treatment-resistant depression. These devices are surgically implanted in the brain to deliver electrical pulses to specific neural targets, modulating brain activity and alleviating debilitating symptoms.

Similarly, vagus nerve stimulation (VNS) implants are being explored for treating epilepsy and depression by stimulating the vagus nerve, a major pathway connecting the brain to various organs. The growing acceptance of neuromodulation therapies, coupled with advancements in miniaturization and wireless technologies, is expected to propel the demand for these specialized implants in the coming years. Another fascinating development within the global medical implant landscape involves the burgeoning field of bioresorbable implants. These implants are designed from materials that gradually dissolve within the body after fulfilling their therapeutic function.

This eliminates the need for a second surgery to remove the implant, reducing patient discomfort and recovery time. Bioresorbable implants hold immense promise for various applications, particularly in orthopedics. For instance, bioresorbable screws and plates used for fracture repair can degrade over time as the bone heals, eliminating the need for a follow-up surgery to remove hardware. Similarly, bioresorbable stents used to open blocked arteries can dissolve after successfully restoring blood flow, minimizing the risk of long-term complications associated with permanent metallic stents. The ongoing research and development efforts in bioresorbable materials are constantly expanding the possibilities for these innovative implants, paving the way for minimally invasive and patient-centric surgical procedures.

According to the research report, “Global Medical Implants Market Overview, 2024-29”, the market is anticipated to cross USD 150 Billion by 2029, increasing from USD 98.55 Billion in 2023. The market is expected to grow with 7.52% CAGR by 2024-29. In developed regions like North America and Europe, a focus on improving the quality of life for an aging population translates to a significant demand for joint replacement implants, particularly for hips and knees. These procedures enable individuals to regain mobility and independence, allowing them to live longer and more fulfilling lives.

Furthermore, the prevalence of chronic diseases like cardiovascular ailments and diabetes necessitates a steady demand for pacemakers, stents, and insulin pumps. These implants play a vital role in managing these chronic conditions and improving patient outcomes. In contrast, developing regions in Asia and Africa present a distinct picture. While the need for advanced implants for chronic disease management exists, a significant portion of the market focuses on addressing the burden of infectious diseases and traumatic injuries. Here, the demand for orthopedic implants for fracture repair is high, particularly in regions with a higher incidence of traffic accidents and workplace injuries.

Additionally, the growing focus on maternal healthcare creates a demand for specialized implants used in obstetrics and gynecology procedures. Furthermore, a rise in disposable income in these regions is leading to an increased interest in cosmetic surgeries, which in turn fuels the demand for certain types of facial implants. This regional diversity extends beyond the specific implant types in demand. Developed nations often boast a well-established infrastructure for advanced surgical procedures and post-operative care, which facilitates the adoption of complex and technologically sophisticated implants. In contrast, developing regions might prioritize the affordability and ease of use of implants, particularly in areas with limited access to specialist surgeons and advanced healthcare facilities.

Market Drivers

  • Rising Focus on Minimally Invasive Surgery (MIS): The global medical implants market is experiencing a significant surge in demand for implants designed for minimally invasive surgical (MIS) procedures. This trend is driven by several factors, including a growing patient preference for less invasive treatments. MIS procedures offer numerous advantages over traditional open surgeries, including shorter hospital stays, reduced post-surgical pain, and faster recovery times. Furthermore, advancements in surgical techniques and instrumentation have made MIS procedures more feasible for a wider range of surgeries, further propelling the demand for specialized implants compatible with these minimally invasive techniques. Manufacturers are actively developing new implant designs and materials specifically suited for MIS procedures, ensuring optimal functionality and compatibility with minimally invasive surgical tools. This focus on MIS is expected to remain a key driver of growth in the global medical implants market for the foreseeable future.
  • The Rise of Personalized Medicine and Patient-Specific Implants: he global medical implants market is witnessing a growing emphasis on personalization and customization. This trend is fueled by advancements in medical imaging technologies and 3D printing. 3D printing allows for the creation of patient-specific implants tailored to a patient's unique anatomy. These customized implants offer several advantages, including improved surgical fit and reduced risk of complications. For instance, 3D-printed joint replacements can be designed to perfectly match a patient's bone structure, potentially leading to better long-term outcomes and increased patient satisfaction. Additionally, the growing adoption of personalized medicine approaches in various therapeutic areas necessitates the development of implants tailored to individual patient needs. This trend towards personalization is expected to have a significant impact on the design, production, and regulatory landscape of the global medical implants market.
  • The Booming Medical Tourism Industry and its Impact on Implant Demand: The global medical tourism industry is experiencing significant growth, with patients increasingly seeking medical care overseas. This phenomenon is driven by factors like cost advantages, availability of advanced procedures, and shorter waiting times in some countries. The rise of medical tourism creates a unique demand for medical implants, particularly in destinations known for high-quality healthcare and advanced surgical procedures. Hospitals catering to medical tourists often require a wider range of sophisticated implants to accommodate the diverse medical needs of patients traveling from abroad. This trend presents an opportunity for medical implant manufacturers to expand their global reach and cater to the specific needs of medical tourism destinations. However, ensuring regulatory compliance, maintaining quality standards, and addressing potential ethical concerns associated with medical tourism are crucial aspects to consider in this evolving landscape.

Market Challenges

  • Threat of Counterfeit Implants: The growing demand for medical implants, particularly in developing nations, has unfortunately created a breeding ground for counterfeit products. These counterfeit implants, often manufactured with substandard materials and lacking proper sterilization procedures, pose a severe threat to patient safety. They can lead to implant failure, infections, and even death. The global nature of the medical implant supply chain, coupled with weak regulatory frameworks in some regions, facilitates the proliferation of these counterfeit products. Addressing this challenge requires a multi-pronged approach. Governments need to strengthen border controls and implement stricter regulations to deter the manufacturing and distribution of counterfeits. Manufacturers, on the other hand, can adopt anti-counterfeiting measures like unique identification tags and secure packaging to ensure the authenticity of their products. Furthermore, raising awareness among healthcare providers and patients about the dangers of counterfeit implants is crucial to mitigate the risks associated with these dangerous products.
  • Ethical Concerns and Equitable Access: Advancements in medical implant technology have the potential to revolutionize healthcare. However, ethical considerations surrounding these advancements require careful attention. The high cost of some cutting-edge implants can create a disparity in access, potentially exacerbating existing healthcare inequalities. This raises the question of affordability and equitable access to these life-saving technologies, particularly in low- and middle-income countries. Finding a balance between fostering innovation and ensuring affordability is paramount. Governments can play a role by implementing price control mechanisms and establishing reimbursement programs to make these advanced implants accessible to a broader patient population. Additionally, collaborations between public and private entities can lead to the development of more cost-effective implant solutions without compromising on quality or safety.
  • Cybersecurity Threats and Data Security: The increasing reliance on digital technologies within the medical implant landscape presents a new set of challenges. Medical implants with embedded sensors and wireless connectivity capabilities offer the potential for remote monitoring and personalized patient care. However, these connected implants introduce vulnerabilities to cyberattacks. Hacking into these devices could compromise patient data or even manipulate their functionality, potentially leading to serious health complications. Furthermore, data security concerns surrounding patient information collected through these implants need to be addressed. Robust cybersecurity measures and stringent data privacy regulations are crucial to ensure patient safety and build trust in this evolving field. Collaboration between medical device manufacturers, healthcare providers, and cybersecurity experts is essential to develop comprehensive safeguards against cyber threats and data breaches in the global medical implant market.

Market Trends

  • The Integration of Artificial Intelligence (AI) in Implant Design and Surgery: The global medical implants market is on the verge of a significant transformation driven by the integration of artificial intelligence (AI). AI has the potential to revolutionize various aspects of the medical implant landscape, from design and development to surgical planning and patient care. For instance, AI algorithms can be used to analyze patient data and generate simulations to optimize implant design for improved functionality and longevity. Additionally, AI-powered surgical planning tools can assist surgeons in performing complex procedures with greater precision and accuracy, potentially leading to better patient outcomes. The integration of AI in the medical implants market is still in its nascent stages, but it holds immense promise for the future, offering greater efficiency, personalization, and improved patient care.
  • The Growing Focus on Smart Implants and Connected Care: The concept of 'smart implants' is gaining traction within the global medical implants market. These implants are equipped with biosensors that can collect and transmit data on a patient's health status. This data can be used by healthcare providers to monitor patient progress, identify potential complications early on, and personalize treatment plans. For instance, smart pacemakers can continuously monitor a patient's heart rhythm and transmit the data to their doctor, allowing for proactive intervention if needed. The integration of smart implants with connected care platforms further enhances patient care by enabling remote monitoring and timely interventions. This trend towards smart implants and connected care is expected to transform postoperative care and patient management within the global medical implants market.
  • The Increasing Focus on Sustainability and Biocompatible Materials: Sustainability is becoming a growing concern within the global medical implants market. Manufacturers are increasingly focusing on developing implants from biocompatible and recyclable materials. This shift is driven by a growing awareness of the environmental impact of traditional implant materials and the potential for these materials to wear down and release particles into the body over time. Biocompatible materials offer a safer and more sustainable alternative, potentially reducing the risk of long-term complications and revisions. Furthermore, advancements in bioprinting technologies hold promise for the development of implants using biocompatible materials derived from a patient's own cells, potentially reducing the risk of rejection and further enhancing patient outcomes.
Orthopaedic implants lead in the Medical Implant market attributed to its disease burden, and economic considerations.

An aging population is a key driver. As life expectancy increases worldwide, the number of individuals susceptible to age-related musculoskeletal disorders like osteoarthritis and osteoporosis also rises. These conditions necessitate various orthopedic implants for treatment, from joint replacements like hips and knees to spinal implants for fusion procedures and fracture fixation devices. The rising prevalence of sports injuries and growing awareness of minimally invasive surgical techniques for orthopedic procedures further fuel demand within this segment. Developed economies like North America and Europe traditionally hold a strong position in the orthopedic implants market.

These regions boast established healthcare infrastructure, a high concentration of skilled orthopedic surgeons, and a willingness to adopt advanced implant technologies. However, the fastest growth is expected to emanate from emerging economies in Asia Pacific and Latin America. Rapid economic development in these regions translates to rising disposable incomes, increasing access to quality healthcare, and a burgeoning middle class more likely to seek treatment for musculoskeletal conditions. Furthermore, the high prevalence of osteoporosis, particularly in Asian countries, necessitates a growing demand for orthopedic implants like bone screws and plates for fracture fixation.

Looking ahead, the orthopedic implants segment is expected to maintain its leadership position within the global medical implant market. Technological advancements like the development of personalized implants and robotic-assisted surgery are poised to further enhance patient outcomes and potentially reduce recovery times. Additionally, the increasing focus on minimally invasive surgical techniques for joint replacements is expected to create a demand for specialized orthopedic implants designed for these procedures.

Metallic materials are the most commonly used materials in the Medical Implant market due to their exceptional combination of strength, durability, and biocompatibility.

On a global scale, metallic biomaterials reign supreme within the medical implant market, capturing a significant share exceeding both polymeric and ceramic alternatives. This dominance can be attributed to the unique properties metallic biomaterials possess, making them ideally suited for a wide range of implant applications. Their exceptional strength, durability, and high load-bearing capacity make them the preferred choice for implants designed to withstand significant stress. For instance, orthopedic implants like hip and knee replacements heavily rely on metallic biomaterials, particularly titanium and cobalt-chromium alloys.

These metals offer the necessary strength and stability to support the weight and movement of the human body, ensuring long-term implant functionality and improved patient outcomes. Furthermore, metallic biomaterials exhibit good biocompatibility, meaning they are generally well-tolerated by the human body and have a low risk of rejection. This characteristic is crucial for long-term implantation, minimizing the need for revision surgeries and associated complications. The versatility of metallic biomaterials extends beyond orthopedic applications.

Cardiovascular implants like stents, which are tiny tubes inserted into arteries to keep them open, often utilize metallic materials due to their ability to maintain their shape and resist deformation within the high-pressure environment of the circulatory system. Similarly, dental implants, which function as artificial tooth roots, frequently rely on titanium due to its biocompatibility and ability to osseointegrate, meaning it fuses with the jawbone over time, providing a strong foundation for dental restorations. However, the dominance of metallic biomaterials is not without its challenges. One concern is the potential for corrosion, particularly in environments with high salinity, like the human body.

Advanced manufacturing techniques and the development of new corrosion-resistant alloys are mitigating this risk. Another consideration is the potential for stress shielding, where the implant absorbs most of the stress during movement, weakening the surrounding bone. Strategic design modifications and the exploration of alternative materials like porous metals are being explored to address this issue. Looking ahead, the future of metallic biomaterials in the global medical implant market appears promising. Continued advancements in material science are expected to yield even stronger, lighter, and more corrosion-resistant alloys, further expanding their application range.

North America leads in the Medical Implant market due to the region’s demographics, economic strength, and robust healthcare infrastructure.

A high concentration of the aging population in North America fuels demand for various medical implants. This demographic segment is particularly susceptible to age-related conditions like osteoarthritis and cardiovascular diseases, necessitating joint replacements, pacemakers, and other implants for improved quality of life. Furthermore, North America boasts a well-developed healthcare system with advanced medical facilities and a high concentration of skilled surgeons. This translates into a higher adoption rate of advanced surgical procedures and specialized implants compared to other regions. The growing emphasis on minimally invasive surgeries in North America further propels the market.

These procedures offer faster recovery times and reduced pain, leading to a preference for these techniques among patients. This, in turn, necessitates the use of specialized implants designed for these minimally invasive approaches. Beyond demographics and healthcare infrastructure, the economic strength of North America plays a crucial role. High disposable incomes and a growing focus on preventive healthcare create a favorable environment for patients to invest in advanced medical implants. Additionally, a robust private insurance market ensures coverage for many implant procedures, further stimulating demand.

This financial security allows patients to prioritize advanced technologies that may offer superior long-term outcomes, even if they come with a higher upfront cost. However, challenges remain. Rising healthcare costs and concerns about affordability are prompting discussions about value-based healthcare, where the focus shifts to cost-effectiveness and demonstrating the long-term benefits of implants. Manufacturers must navigate this changing landscape by developing innovative yet cost-conscious solutions. Furthermore, ensuring equitable access to these advanced medical implants across all income brackets remains an ongoing effort. Government initiatives and insurance reforms can play a crucial role in bridging this gap and ensuring that these life-changing technologies are accessible to a broader patient population in North America.

Recent Developments

  • April 2024: In a significant development for the chronic pain management market, Medtronic, a leading medical device company, recently secured approval from the US Food and Drug Administration (FDA) for its innovative Intellis™ DBS System. This novel device represents a groundbreaking spinal cord stimulation (SCS) technology with the potential to revolutionize pain management for patients suffering from chronic pain conditions. The Intellis™ DBS System is the world's first SCS system to feature directional DBS (Directional DBS) technology. This directional targeting capability allows for more precise stimulation of the spinal cord, potentially offering improved pain relief and fewer side effects compared to traditional SCS devices. The FDA approval was based on the results of the pivotal Precision spinal cord stimulation trial. The trial demonstrated that the Intellis™ DBS System effectively reduced chronic pain in patients with failed back surgery syndrome (FBSS). Patients who received the directional DBS therapy reported significant improvements in pain relief compared to those receiving conventional SCS.
  • March 2024: A recent development in the cardiovascular technology space highlights the progress of minimally invasive defibrillator implants. McLaren Flint, a part of McLaren Health Care, is among the first hospitals in the US to successfully implant the Aurora Evera EV-ICD system. This next-generation defibrillator is placed under the breastbone, outside the heart and veins, offering a less risky alternative to traditional implants for patients with irregular heart rhythms. This technology signifies advancements in cardiac care, aiming to reduce potential complications associated with conventional defibrillators.
  • February 2024: Canary Medical, a company previously known for its smart orthopedic implants, has shifted its focus to the cardiovascular space. The company has completed an initial human trial of a sensor-equipped cardiac implant designed to detect abnormalities like leaky valves through analysis of heart sounds. This shift in focus highlights the growing potential of smart implants for applications beyond bones and joints, potentially expanding the market for these advanced medical devices.
  • December 2023: A collaborative effort between Singapore General Hospital (SGH) and Nanyang Technological University (NTU Singapore) aims to revolutionize patient care through the development of customized medical devices and implants using 3D printing technology. This initiative signifies a significant leap towards pioneering healthcare solutions with the potential to redefine treatment approaches. The establishment of a Joint Research & Development Laboratory in additive manufacturing (AM), also known as 3D printing, will focus on creating patient-specific implants and devices. This technology offers a high degree of customization, allowing for the creation of implants that perfectly match a patient's unique anatomy. This could lead to improved surgical outcomes, faster healing times, and reduced risks of complications associated with off-the-shelf implants.
  • November 2023: Hindustan Unilever (HUL), Unilever's India business, in partnership with TFL and Fertiglobe, is piloting the production of near-zero emissions synthetic Medical Implant, a key ingredient in laundry powder. This initiative aims to reduce greenhouse gas emissions throughout the manufacturing process. The pilot will produce enough Medical Implant for about 6,000 tonnes of laundry powder. Beyond the pilot, HUL has signed an agreement for low GHG Medical Implant made with renewable energy and CO2 capture and use, offering a reduction of over 60% in emissions. This project aligns with Unilever's commitment to achieving net zero emissions and highlights their focus on sustainable ingredient sourcing.

Considered in this report

  • Historic year: 2018
  • Base year: 2023
  • Estimated year: 2024
  • Forecast year: 2029

Aspects covered in this report

  • Medical Implant market Outlook with its value and forecast along with its segments
  • Various drivers and challenges
  • On-going trends and developments
  • Top profiled companies
  • Strategic recommendation

By Product Type

  • Orthopaedic Implants
  • Cardiovascular Implants
  • Spinal Implants
  • Structural Cardiac Implants
  • Neuro-stimulators
  • Dental Implants
  • Facial Implants
  • Breast implants

By Type of Material

  • Polymers Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • Natural Biomaterial)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. After this, the analyst started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once the analyst had primary data, they started verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Medical Implant industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

This product will be delivered within 2 business days.

Table of Contents

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. COVID-19 Effect
2.5. Supply chain Analysis
2.6. Policy & Regulatory Framework
2.7. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Medical Implant Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product Type
6.5. Market Size and Forecast, By Type of Material
7. North America Medical Implant Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product Type
7.4. Market Size and Forecast, By Type of Material
8. Europe Medical Implant Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product Type
8.4. Market Size and Forecast, By Type of Material
9. Asia-Pacific Medical Implant Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product Type
9.4. Market Size and Forecast, By Type of Material
10. South America Medical Implant Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product Type
10.4. Market Size and Forecast, By Type of Material
11. Middle East & Africa Medical Implant Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product Type
11.4. Market Size and Forecast, By Type of Material
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2022
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. Stryker Corporation Company Snapshot Company Overview Financial Highlights Geographic Insights Business Segment & Performance Product Portfolio Key Executives Strategic Moves & Developments
12.6.2. Conmed Corporation
12.6.3. Medtronic PLC
12.6.4. Johnson & Johnson Services, Inc.
12.6.5. Zimmer Biomet Holdings, Inc.
12.6.6. Enovis Corporation
12.6.7. Boston Scientific Corporation
12.6.8. BIOTRONIK SE & Co. KG
12.6.9. Abbott Laboratories
12.6.10. Globus Medical, Inc.
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer
List of Figures
Figure 1: Global Medical Implant Market Size (USD Billion) By Region, 2023 & 2029
Figure 2: Market attractiveness Index, By Region 2029
Figure 3: Market attractiveness Index, By Segment 2029
Figure 4: Global Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 5: Global Medical Implant Market Share By Region (2023)
Figure 6: North America Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 7: North America Medical Implant Market Share By Country (2023)
Figure 8: Europe Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 9: Europe Medical Implant Market Share By Country (2023)
Figure 10: Asia-Pacific Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 11: Asia-Pacific Medical Implant Market Share By Country (2023)
Figure 12: South America Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 13: South America Medical Implant Market Share By Country (2023)
Figure 14: Middle East & Africa Medical Implant Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 15: Middle East & Africa Medical Implant Market Share By Country (2023)
Figure 16: Competitive Dashboard of top 5 players, 2023
Figure 17: Market Share insights of key players, 2023
Figure 18: Porter's Five Forces of Global Medical Implant Market
List of Tables
Table 1: Global Medical Implant Market Snapshot, By Segmentation (2023 & 2029) (in USD Billion)
Table 2: Influencing Factors for Medical Implant Market, 2023
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Medical Implant Market Size and Forecast, By Geography (2018 to 2029F) (In USD Billion)
Table 7: Global Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 8: Global Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)
Table 9: North America Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 10: North America Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)
Table 11: Europe Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 12: Europe Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)
Table 13: Asia-Pacific Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 14: Asia-Pacific Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)
Table 15: South America Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 16: South America Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)
Table 17: Middle East & Africa Medical Implant Market Size and Forecast, By Product Type (2018 to 2029F) (In USD Billion)
Table 18: Middle East & Africa Medical Implant Market Size and Forecast, By Type of Material (2018 to 2029F) (In USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Stryker Corporation
  • Conmed Corporation
  • Medtronic PLC
  • Johnson & Johnson Services, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Enovis Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Globus Medical, Inc.